SANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today ...
Bivision Pharmaceuticals (Shanghai) Co. Ltd. has identified cyclic peptides targeting fibroblast activating protein α (FAP) reported to be useful for the treatment of cancer.
More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans. Rheumatoid arthritis is an autoimmune, inflammatory form of arthritis, meaning a ...
Cancer imaging company Kuva Labs is expanding its scope via the acquisition of solid tumor biotech Lisata Therapeutics. The big prize for Kuva is certepetide, Lisata’s cyclic peptide drug that the ...
Abstract: Based on the principle of nanoparticle immuno turbidimetry, this study optimized the nanoparticle particle size, buffer pH, activator concentration and sealer concentration in the ...
VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech working on oral macrocyclic peptide drugs—a mission that has already reeled in a partnership with Biogen. The biopharma has paid $50 ...
After af_model.prep_inputs(), I added some code to replace the original linear offset_matrix with the cyclic peptide offset matrix. Then I performed de novo design for the cyclic peptide. However, the ...
Good morning, and welcome to the Hansa Biopharma virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Hansa's website ...
Abstract: Cyclic peptides become attractive therapeutic candidates due to their diverse biological activities. However, existing deep learning-based sequence design models, such as ProteinMPNN, are ...
SHANGHAI, Sept. 2, 2025 /PRNewswire/ -- Peptides have recently emerged at the forefront of therapeutic innovation, with cyclic peptides gaining particular attention for their ability to bridge the gap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results